Jing Wei
Jiang Xi Institute for Drug Control(CN)
Publications by Year
Research Areas
Tissue Engineering and Regenerative Medicine, Bone Tissue Engineering Materials, Electrospun Nanofibers in Biomedical Applications, Immune Cell Function and Interaction, Mesenchymal stem cell research
Most-Cited Works
- → Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins(2004)1,362 cited
- → Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression(2009)429 cited
- → Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells(2020)312 cited
- → Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression(2008)262 cited
- → Biomarkers in heart failure: the past, current and future(2019)125 cited
- Hepatitis C virus non-structural protein NS4B can modulate an unfolded protein response.(2005)
- → Berberine Facilitates Angiogenesis Against Ischemic Stroke Through Modulating Microglial Polarization via AMPK Signaling(2019)104 cited
- → Vancomycin- and Strontium-Loaded Microspheres with Multifunctional Activities against Bacteria, in Angiogenesis, and in Osteogenesis for Enhancing Infected Bone Regeneration(2019)89 cited
- → Constructing conductive conduit with conductive fibrous infilling for peripheral nerve regeneration(2018)87 cited
- → Characterization of Th17 and FoxP3+ Treg Cells in Paediatric Psoriasis Patients(2015)75 cited